Coronary thrombosis in diabetes: Are we doing enough?

Diab Vasc Dis Res. 2016 Nov;13(6):445-448. doi: 10.1177/1479164116663795. Epub 2016 Aug 23.
No abstract available

MeSH terms

  • Coronary Thrombosis / diagnosis
  • Coronary Thrombosis / epidemiology
  • Coronary Thrombosis / mortality
  • Coronary Thrombosis / prevention & control*
  • Diabetes Complications / diagnosis
  • Diabetes Complications / epidemiology
  • Diabetes Complications / mortality
  • Diabetes Complications / prevention & control*
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Primary Prevention
  • Risk Factors
  • Secondary Prevention
  • Time Factors
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors